Nasir Khan

Nasir Khan is an experienced biopharmaceutical professional currently serving as the Executive Director and Head of Technical Operations Strategy and Business Operations at Sarepta Therapeutics since July 2023. As a Co-Founder and Advisory Board Member at AbBC Therapies since March 2014, Nasir is involved in developing innovative antibody-drug conjugates. Previously, Nasir held various leadership roles at Johnson & Johnson and its subsidiaries, focusing on CMC portfolio optimization, external manufacturing, and technical operations for biologics. Notable achievements include leading CMC efforts for the nipocalimab program at Momenta Pharmaceuticals and contributing to significant advancements in cell line engineering and process development at AVEO Oncology. Nasir's earlier career includes key positions at Thallion Pharmaceuticals, DSM, and Alexion Pharmaceuticals, complemented by a Bachelor's degree in Molecular Genetics from the University of Connecticut.